Ending the TB Epidemic
Current therapy for MDR TB requires the use of multiple, toxic, and expensive drugs for 18–24 months. The introduction of two new medications to treat MDR TB—bedaquiline (BDQ) and delamanid (DLM)—has renewed hope for the nearly half million people with MDR-TB. Join us in contacting ministries of health to urge faster progress in increasing access to these medications, and inform parliamentarians and other officials.Take action!
Ending the TB EpidemicInvesting in NutritionThe Power of Vaccines
ACTION is always interested in hearing from you, so check out how you can join us in achieving more together.Join us